These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25018649)

  • 1. Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series.
    Casale R; Di Matteo M; Minella CE; Fanelli G; Allegri M
    J Pain Res; 2014; 7():353-7. PubMed ID: 25018649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
    Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
    Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
    Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
    Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
    Hans G; Sabatowski R; Binder A; Boesl I; Rogers P; Baron R
    Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of 5% lidocaine-medicated plaster compared with pregabalin for the treatment of post-herpetic neuralgia in China.
    Zeng F; Wang M; Zhang D
    Ann Palliat Med; 2021 Apr; 10(4):4493-4501. PubMed ID: 33894728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Ritchie M; Liedgens H; Nuijten M
    Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence.
    de León-Casasola OA; Mayoral V
    J Pain Res; 2016; 9():67-79. PubMed ID: 26929664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia.
    Garnock-Jones KP; Keating GM
    Drugs; 2009 Oct; 69(15):2149-65. PubMed ID: 19791831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
    Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
    Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use.
    Baron R; Allegri M; Correa-Illanes G; Hans G; Serpell M; Mick G; Mayoral V
    Pain Ther; 2016 Dec; 5(2):149-169. PubMed ID: 27822619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized peripheral neuropathic pain: topical treatment with lidocaine 700 mg medicated plaster in routine clinical practice.
    Überall MA; Bösl I; Hollanders E; Sabatschus I; Eerdekens M
    Pain Manag; 2022 May; 12(4):521-533. PubMed ID: 35001660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G; Correa-Illanes G
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Localized neuropathic pain--5% lidocaine medicated patch as a first-line treatment and as add-on therapy: literature review and personal experience].
    Casale R; Polati E; Schweiger V; Coluzzi F; Bhaskar A; Consalvo M
    Minerva Med; 2014 Jun; 105(3):177-95. PubMed ID: 24988084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
    Amato F; Duse G; Consoletti L; Lo Presti C; Firetto V; Ciliberto G; Parigi LA; Palmieri V; Mazza M
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4228-4235. PubMed ID: 29028074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia.
    Liedgens H; Obradovic M; Nuijten M
    Clinicoecon Outcomes Res; 2013 Nov; 5():597-609. PubMed ID: 24348056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
    Rehm S; Binder A; Baron R
    Curr Med Res Opin; 2010 Jul; 26(7):1607-19. PubMed ID: 20429825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.